News
San Antonio's Texas Biomed CEO responds to potentially major changes in the FDA's approach to drug development research.
The National Institutes of Health (NIH) terminated the Texas State U-RISE program and the Texas Doctoral Bridge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback